CymaBay announces closing of public offering of common stock
CymaBay Therapeutics announced the closing of its previously announced underwritten public offering of its common stock. CymaBay sold 14,950,000 shares of its common stock in the offering, including 1,950,000 shares pursuant to the full exercise of the underwriters’ option. July 24, 2017